|Event Name||Science, the State and the City: Britain’s struggle to imitate US success in Biotechnology - and its lessons for industrial strategy|
|Start Date||25th Sep 2017 3:30pm|
|End Date||25th Sep 2017 5:00pm|
|Duration||1 hour and 30 minutes|
To get to the room do NOT go up the steps to the main entrance to 7 Bristo Square, go past these steps and down a couple of steps from street level and the room is there.
This presentation summarises the argument of 'Science, the State and the City' by Geoffrey Owen and Michael Hopkins (2016), exploring potential answers to the following questions: (i) Why it has been so difficult for the UK to produce large therapeutic biotech firms similar to those seen in the USA? (ii) why have UK firms not been able to commercialise therapeutic drugs to rival those that US firms have brought to market? Of course the therapeutic biotech sector (which aims to develop novel drugs) is not the only sector in which countries have struggled to emulate US success and so answers to these questions have implications for other, particularly knowledge-intensive, sectors.